United Kingdom

People: Piramal Enterprises Ltd (PIRA.NS)

PIRA.NS on National Stock Exchange of India

11:29am BST
Change (% chg)

Rs-73.90 (-3.89%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

DeYoung, Peter 

Mr. Peter DeYoung serves as Chief Executive Officer - Piramal Critical Care of the company. He is the CEO of Piramal Critical Care. He is a member of the Piramal Pharma Operating Board and also a member of the Board of Piramal Imaging SA. Prior to joining Piramal, he worked in a range of investing and consulting roles in healthcare in the US, Europe and India. He joined McKinsey & Company in New York after graduating from Princeton, where he worked on a number of projects for pharmaceutical and medical device companies. He was then seconded by McKinsey to the World Economic Forum in Geneva, Switzerland as a Project Manager for the Global Health Initiative, where he implemented an HIV/AIDS, TB and malaria advocacy strategy focused on boosting private sector programmes in South East Asia and Africa. He then returned to McKinsey as an Engagement Manager in New York and later in Mumbai, where he focused on the pharmaceutical and healthcare practice. He helped clients address a range of strategic, organisational, and operational challenges. He then went on to join the Blackstone’s Private Equity Group in Mumbai. He was on the deal team for several significant transactions across a variety of industry sectors in India. He completed his Bachelors of Science in Engineering from Princeton University, New Jersey, USA (summa cum laude, phi beta kappa, tau beta pi) and his Masters of Business Administration at Stanford University (Arjay Miller Scholar), California, USA.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ajay Piramal


Swati Piramal


Vivek Valsaraj


Peter DeYoung


Jonathan Sandler


Vivek Sharma

As Of  31 Mar 2018